Cargando…

Cross-Reactivity of Antibodies in Intravenous Immunoglobulin Preparation for Protection against SARS-CoV-2

Severe cases of COVID-19 continue to put pressure on medical operations by prolonging hospitalization, occupying intensive care beds, and forcing medical personnel to undergo harsh labor. The eradication of SARS-CoV-2 through vaccine development has yet to be achieved, mainly due to the appearance o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osaka, Toshifumi, Yamamoto, Yoko, Soma, Takehisa, Yanagisawa, Naoko, Nagata, Satoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959286/ https://www.ncbi.nlm.nih.gov/pubmed/36838436 http://dx.doi.org/10.3390/microorganisms11020471

Ejemplares similares

Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations
por: Hooper, John A.
Publicado: (2008)

The Role of Intravenous Immunoglobulin Preparations in the Treatment of Systemic Sclerosis
por: Baleva, Marta, et al.
Publicado: (2011)

Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
por: Stinca, Sara, et al.
Publicado: (2021)

SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice
por: El-Kafrawy, Sherif A., et al.
Publicado: (2022)

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2
por: Ahn, Terrie S., et al.
Publicado: (2021)

Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin
por: Bae, Sangmee Sharon, et al.
Publicado: (2023)

In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations
por: Dhainaut, F, et al.
Publicado: (2013)

Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
por: Colado, Ana, et al.
Publicado: (2021)

Antifungal antibodies present in intravenous immunoglobulin derived from China
por: Wang, Yanfang, et al.
Publicado: (2023)

Epitope Predictions Indicate the Presence of Two Distinct Types of Epitope-Antibody-Reactivities Determined by Epitope Profiling of Intravenous Immunoglobulins
por: Luštrek, Mitja, et al.
Publicado: (2013)

Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin
por: Abghari, Pamella F., et al.
Publicado: (2017)

Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection
por: Rockman, Steven, et al.
Publicado: (2017)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Intravenous Immunoglobulin Prevents Murine Antibody-Mediated Acute Lung Injury at the Level of Neutrophil Reactive Oxygen Species (ROS) Production
por: Semple, John W., et al.
Publicado: (2012)

Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin
por: Sali, Aggeliki D, et al.
Publicado: (2015)

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies
por: Berzero, Giulia, et al.
Publicado: (2018)

Intravenous immunoglobulin preparations attenuate lysolecithin-induced peripheral demyelination in mice and comprise anti-large myelin protein zero antibody
por: SETOGUCHI, Yuki, et al.
Publicado: (2023)

Seroprevalence of antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) in household dogs in Japan
por: ITO, Genta, et al.
Publicado: (2021)

Detection of SARS-CoV-2 Antibodies in Immunoglobulin Products
por: Cousins, Kimberley, et al.
Publicado: (2023)

Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?
por: Reznik, Sandra E., et al.
Publicado: (2022)

SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
por: Lindahl, Hannes, et al.
Publicado: (2023)

Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin
por: Parker, Simon, et al.
Publicado: (2014)

Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products
por: Lee, Soyoung, et al.
Publicado: (2016)

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
por: Rogier, Thomas, et al.
Publicado: (2020)

Epstein–Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity
por: Nagata, Keiko, et al.
Publicado: (2020)

A041 DETECTION OF SARS-COV-2 ANTIBODIES IN IMMUNOGLOBULIN PRODUCTS
por: Cousins, K., et al.
Publicado: (2021)

Reactive infectious mucocutaneous eruption – repeat etanercept after intravenous immunoglobulin: A case report
por: Tonkin, Rochelle, et al.
Publicado: (2022)

Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias
por: Higo, Hisao, et al.
Publicado: (2022)

Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses
por: Yamamoto, Haruko, et al.
Publicado: (2022)

Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
por: Díez, José María, et al.
Publicado: (2020)

Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
por: Tang, Juanjie, et al.
Publicado: (2021)

Anti-feline panleukopenia virus serum neutralizing antibody titer in domestic cats with the negative or low hemagglutination inhibition antibody titer
por: SOMA, Takehisa, et al.
Publicado: (2018)

Widespread impact of immunoglobulin V gene allelic polymorphisms on antibody reactivity
por: Yuan, Meng, et al.
Publicado: (2023)

Widespread impact of immunoglobulin V-gene allelic polymorphisms on antibody reactivity
por: Yuan, Meng, et al.
Publicado: (2023)

Protective anti‐prion antibodies in human immunoglobulin repertoires
por: Senatore, Assunta, et al.
Publicado: (2020)

Intravenous Immunoglobulin in the Management of Lupus Nephritis
por: Wenderfer, Scott E., et al.
Publicado: (2012)

Pemphigoid gestationis and intravenous immunoglobulin therapy()
por: Yang, Anes, et al.
Publicado: (2018)

Intravenous Immunoglobulin for Overwhelming Postsplenectomy Infection
por: Nakamura, Kensuke, et al.
Publicado: (2021)

Intravenous Immunoglobulin: Revisited – My Experience
por: Vaishampayan, Sanjeev S., et al.
Publicado: (2021)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dvocc6mhr0q4nrhqn8cckl1brd